FHTX Chart
- 52-Week Range: $8.33 - $22.87
- Market Capitalization: $474.81M
- Short Percentage: 0%
- Target Price: $28.25
- Shares Outstanding: 41.47M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
FHTX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Foghorn Therapeutics to Present Preclinical Data For FHD-286 at the 2022 AACR Annual MeetingGlobeNewsWire | April 1st
- Foghorn Therapeutics to Participate at the 2022 Guggenheim Targeted Protein Degradation DayGlobeNewsWire | March 11th
- Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 OutlookGlobeNewsWire | March 10th
- Foghorn Therapeutics to Participate at the Cowen's 42nd Annual Health Care ConferenceGlobeNewsWire | February 28th
- Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect ConferenceGlobeNewsWire | January 7th
- FHTX Stock Alert: 7 Things to Know About the Partnership Lifting Foghorn TodayInvestorPlace | December 13th
- Foghorn Therapeutics Announces Presentation at Upcoming 4th Annual Targeted Protein Degradation SummitGlobeNewsWire | October 19th
- Foghorn Therapeutics to Participate in Two Upcoming Virtual Investor ConferencesGlobeNewsWire | September 1st
Company Info
Website: https://foghorntx.com
Address: 500 Technology Square, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 119
Address: 500 Technology Square, Cambridge, MA, United States, 02139
Sector: Healthcare
Industry: Biotechnology
Full time employees: 119
$FHTX has just been halted from trading.
$FHTX Be patient !!
$FHTX the catalyst we need !
$FHTX holdddd it tight yall
$FHTX oh my!
$FHTX CHUG CHUG CHUG
$FHTX Momentum is building...
$FHTX Bears always win...
Bulls have to be forever bagholders....
$FHTX has just been halted from trading due to volatility.
$FHTX wow! I sold too early